BC-CfE researchers will be presenting at this year’s AIDS 2017 conference

IAS 2017

The International AIDS Conference is the premier gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. It is a chance to assess where we are, evaluate recent scientific developments and lessons learnt, and collectively chart a course forward.

The AIDS 2017 conference will be held at the Palais des Congrès, 2 Place de la Porte Maillot, Paris from 23 to 26 July 2017.

Click HERE to visit the AIDS 2017 website for more information

Once again, BC-CfE researchers will be presenting at this year’s AIDS 2017 conference.


Presenters Presentation Date Topic PDF Downloads
Brad Jones
Co-op Student | BC-CfE Laboratory Program
Monday, July 24th Heterogeneous age and genetic distribution of within-host HIV-1 reservoirs revealed by a novel phylogenetic dating strategy
María Eugenia Socías
Postdoctoral Fellow | BCCSU
Monday, July 24th Trends of transmitted drug resistance among HIV-positive people who use drugs, Vancouver, Canada
Nathan Lachowsky
Assistant Professor
Monday, July 24th Crystal methamphetamine initiation among HIV-positive and HIV-negative men who have sex with men in Vancouver, Canada: a longitudinal analysis
Ignacio Rozada
Mathematical Modeler | Epidemiology and Population Health
Monday, July 24th The potential effect of initiating combination antiretroviral therapy with integrase Inhibitors on HIV transmission risk in British Columbia, Canada
Alex Collins
Student Research Assistant | Epidemiology and Population Health
Monday, July 24th Addressing the ‘risk environment’: changes in substance use patterns amongst people living in an HIV-specific housing facility in Vancouver, Canada
Surita Parashar
Research Scientist | Epidemiology and Population Health
Monday, July 24th Impact of supportive housing on immunological and virological status and antiretroviral therapy adherence amongst people living with HIV and at risk of homelessness in Vancouver, Canada
Angela Kaida
Principal Investigator | CHIWOS
Monday, July 24th Awareness of HIV non-disclosure case law among women living with HIV in Canada: a call to build women centered knowledge and support around HIV disclosure and the law
Rod Knight
Postdoctoral Fellow | BCCSU
Monday, July 24th Scale-up of treatment as Prevention¨ in British Columbia, Canada: opportunities and challenges identified by policy makers and service providers
Nathan Lachowsky
Assistant Professor
Tuesday, July 25th Prevalence, trends and risk factors of transactional sex among men who have sex with men in metro Vancouver, Canada: a longitudinal event-level analysis Oral Presentation
Kate Salters
Research Assistant | Epidemiology and Population Health
Tuesday, July 25th Cancer mortality among HIV-positive adults in British Columbia, Canada: a retrospective analysis
Ana Ulloa
Research Assistant | Epidemiology and Population Health
Tuesday, July 25th Determination of AIDS- and non-AIDS-related causes of death reported in death certificates as compared to physicians’ reviews in a tertiary referral hospital in Vancouver, British Columbia
Ana Ulloa
Research Assistant | Epidemiology and Population Health
Tuesday, July 25th Examining differences in cause-specific mortality among patients enrolled in a hospital-based HIV care clinic in a Canadian setting
Julio Montaner
Director of the British Columbia Centre for Excellence in HIV/AIDS | Director of IDC and Physician Program Director for HIV/AIDS PHC
Tuesday, July 25th Characterizing HIV antiretroviral therapy interruption and the following disease progression using population-level data in British Columbia, Canada: 1996-2015
Ofer Amram
GIS Analyst | GSHI
Tuesday, July 25th Patterns and correlates of displacement of sex workers and implications for HIV programmes: findings of a community-based project in Vancouver, Canada
Ignacio Rozada
Mathematical Modeler | Epidemiology and Population Health
Tuesday, July 25th Impact of TasP, PrEP and condoms on the HIV epidemic among MSM in British Columbia
Bohdan Nosyk
Research Scientist | HERU, Epidemiology and Population Health
Tuesday, July 25th Using the QALY to evaluate interventions for HIV treatment and prevention: value and ethics
Bohdan Nosyk
Research Scientist | HERU, Epidemiology and Population Health
Tuesday, July 25th The cost-effectiveness of HIV testing and treatment engagement initiatives in British Columbia, Canada: 2011-2013
Jeff Joy
Research Scientist | BC-CfE Laboratory Program
Wednesday, July 26th Phylodynamic insights into HIV epidemic dynamics within Canada 
Lianping (Mint) Ti
Research Scientist, Hepatitis C Research Program | Epidemiology and Population Health
Wednesday, July 26th Co-prescription of benzodiazepines and opioids on hospitalization rates among people living with HIV in British Columbia, Canada
Silvia Guillemi
Director, Clinical Education and Training Program; Assistant Medical Director at IDC
Wednesday, July 26th Incidence and factors associated with atrial fibrillation in people living with human immunodeficiency virus (PLHIV) in British Columbia, Canada
Angela Kaida
Principal Investigator | CHIWOS
Wednesday, July 26th Uptake of safer conception strategies among women living with HIV in Canada who report pregnancy with an HIV-serodiscordant partner
Share the Post:
Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)